Inventor · disambiguated record
Mathias Vormehr
Also filed as: VORMEHR MATHIAS
2 granted patents·11 pending applications·3 citations·filing 2016–2024
42Inventor score
Top patents by PatentIndex Score
13 records- 0182US11156617B2Predicting T cell epitopes useful for vaccinationBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2016·Granted Oct 26, 2021·3 cites·21 claims
- 0268US2025244311A1Methods for predicting the usefulness of proteins or protein fragments for immunotherapyBioNTech SE·Filed 2024·Application pending·0 cites
- 0360US2022074948A1Predicting t cell epitopes useful for vaccinationBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2021·Application pending·0 cites
- 0453US2024335511A1Therapeutic rna for treating cancerBioNTech SE·Filed 2021·Application pending·0 cites
- 0552US2024041999A1Therapeutic RNA for Treating CancerBioNTech SE·Filed 2021·Application pending·0 cites
- 0650US2022378876A1Treatment Involving Therapeutic Antibody and Interleukin-2 (IL2)BioNTech SE·Filed 2020·Application pending·0 cites
- 0749US2023117803A1Treatment involving antigen vaccination and binding agents binding to pd-l1 and cd137BioNTech SE·Filed 2021·Application pending·0 cites
- 0847US12153041B2Methods for predicting the usefulness of proteins or protein fragments for immunotherapyBioNTech SE·Filed 2017·Granted Nov 26, 2024·0 cites·19 claims
- 0947US2024390462A1Treatment Schedule for Cytokine ProteinsBioNTech SE·Filed 2021·Application pending·0 cites
- 1047US2021290746A1Individualized Vaccines for CancerBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2019·Application pending·0 cites
- 1147US2022143144A1Treatment involving interleukin-2 (il2) and interferon (ifn)BioNTech SE·Filed 2020·Application pending·0 cites
- 1245US2021113606A1Treatment using cytokine encoding rnaBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2019·Application pending·0 cites
- 1344US2022356223A1IL2 AgonistsBioNTech SE·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mathias Vormehr files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →